GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Annexin Pharmaceuticals AB (publ) ANNX.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

9.44

+6.07%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Annexin Pharmaceuticals AB (publ) annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
Operating income−SEK 36.3m−SEK 50.5m−SEK 44.2m−SEK 40.7m−SEK 50.5m
Net income−SEK 36.9m−SEK 50.3m−SEK 44.1m−SEK 40.7m−SEK 52.1m
Free cash flow−SEK 37.1m−SEK 50.2m−SEK 86.8m−SEK 41.2m−SEK 45.0m
Total assetsSEK 30.2mSEK 19.0mSEK 26.8mSEK 36.7mSEK 52.8m
Shareholders' equitySEK 24.9mSEK 13.7mSEK 18.8mSEK 30.2mSEK 46.7m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.